GARNETT & SONS AVIATION LIMITED
Company number 14850014 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
GARNETT & SONS AVIATION LIMITED - Analysis Report
Company Number: 14850014
Analysis Date: 2025-07-29 19:22 UTC
Financial Health Assessment Report for GARNETT & SONS AVIATION LIMITED
1. Financial Health Score: F
Explanation:
The company shows a critical financial condition with negative net assets and net current liabilities exceeding current assets. This is a serious symptom indicating insolvency risk and financial distress in its first year of operation.
2. Key Vital Signs
| Metric | Value (£) | Interpretation |
|---|---|---|
| Fixed Assets | 365 | Very low long-term asset base; typical for a micro-entity startup. |
| Current Assets | 4,021 | Limited liquid assets available to cover short-term obligations. |
| Current Liabilities | 9,623 | High short-term debts exceeding current assets, indicating liquidity stress. |
| Net Current Assets | -5,602 | Negative working capital—a strong symptom of cash flow difficulties and inability to meet due debts. |
| Total Assets Less Current Liabilities | -5,237 | Negative net asset position, indicating insolvency on a balance sheet basis. |
| Shareholders’ Funds | -5,237 | Negative equity, meaning the company owes more than it owns; a fundamental red flag. |
3. Diagnosis
The company’s financial "vital signs" reveal a serious condition akin to a patient presenting with severe symptoms of distress:
Negative Net Current Assets: The business has £4,021 in current assets but owes £9,623 in short-term liabilities, resulting in a £5,602 working capital deficit. This "cash flow blockage" symptom indicates the company may struggle to pay suppliers and meet day-to-day expenses without additional financing.
Negative Net Assets / Shareholders’ Funds: The total liabilities outweigh total assets, showing the company is technically insolvent. For a newly incorporated company, this may reflect initial startup losses or capital structure issues.
Minimal Fixed Assets: Only £365 in fixed assets suggests limited investment in property or equipment, which is common for new or small businesses but also means limited collateral for borrowing.
Single Employee: The company is very small-scale (micro entity) with only one employee, which may limit operational capacity but also reduces fixed overhead.
Overall, the company's financial condition is fragile. The negative net assets and working capital deficit are clear symptoms of financial distress. Without corrective action, this could lead to insolvency proceedings.
4. Recommendations
To improve its financial wellness and stabilize operations, the company should consider the following immediate actions:
Infusion of Capital: The shareholder (who owns 75-100%) should consider injecting additional equity or providing director loans to shore up the balance sheet and cover short-term liabilities. This will help restore "healthy blood flow" of funds.
Cost Control Measures: Review all operating expenses and reduce discretionary costs to preserve cash. With only one employee, focus on lean operations and avoid unnecessary overhead.
Improve Cash Flow Management: Negotiate extended payment terms with creditors and accelerate collections (if any receivables exist) to improve liquidity.
Strategic Review: Evaluate business model viability and market positioning to ensure sustainable revenue generation. Given SIC code 85590 (Other education not elsewhere classified), clarify revenue streams and potential growth areas.
Regular Monitoring: Implement monthly cash flow forecasting and financial review processes to detect and address financial strain early.
Seek Professional Advice: Engage with a financial advisor experienced in startup and micro-entity financial restructuring to explore options including grants, loans, or restructuring.
Medical Analogy Summary:
The company is currently in a state of "financial shock," with critical signs of liquidity and solvency failure. Immediate "resuscitation" via capital injection and cost control is essential to prevent "collapse." Without intervention, the prognosis is poor.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.